Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 6/2019

01-06-2019 | Original Article

Distress and quality of life in patient and caregiver dyads facing stem cell transplant: identifying overlap and unique contributions

Authors: Timothy S. Sannes, Teresa L. Simoneau, Susan K. Mikulich-Gilbertson, Crystal L. Natvig, Benjamin W. Brewer, Kristin Kilbourn, Mark L. Laudenslager

Published in: Supportive Care in Cancer | Issue 6/2019

Login to get access

Abstract

Purpose

Allogeneic hematopoietic stem cell transplantation (Allo-HSCT) is a demanding treatment requiring caregiver support. The pre-transplant period is particularly stressful. How patient and caregiver dyads respond to these stressors can impact post-transplant outcomes. The purpose of this cross-sectional study was to assess pre-transplant patient and caregiver distress, patient quality of life (pQoL), and simultaneously investigate relationship between caregiver distress, patient distress, and patient QoL.

Methods

We measured caregiver anxiety, depressive symptoms, perceived stress, sleep quality, caregiver burden, and pQoL in148 dyads compared to clinical thresholds or population norms. To reduce comparisons, we created a composite distress score from affective measures. Associations within dyads were examined via correlation and path analysis.

Results

Most dyads scored above norms for psychological measures. Patient distress was positively associated with caregiver distress. Higher caregiver distress significantly predicted poorer pQoL after accounting for the interdependence of patient and caregiver distress. Specifically, patients’ physical functioning was the primary driver of this interrelationship.

Conclusions

Allo-HSCT patients and their caregivers reported elevated distress pre-transplant. Both patient and caregiver distress contributed to pQoL, with patients’ physical functioning accounting significantly for caregiver well-being. Supporting the patient-caregiver dyad before transplantation is a priority for supportive services.
Literature
1.
Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI, Omel JL, Orchard PJ, Palmer J, Saber W, Savani BN, Veys PA, Bredeson CN, Giralt SA, LeMaistre CF (2015) Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 21(11):1863–1869CrossRefPubMedPubMedCentral
2.
Bevans MF, Mitchell SA, Marden S (2008) The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT). Support Care Cancer 16(11):1243–1254CrossRefPubMedPubMedCentral
3.
Majhail NS, Douglas Rizzo J (2013) Surviving the cure: long term followup of hematopoietic cell transplant recipients. Bone Marrow Transplant 48(9):1145–1151CrossRefPubMed
4.
El-Jawahri AR, Traeger LN, Kuzmuk K, Eusebio JR, Vandusen HB, Shin JA, Keenan T, Gallagher ER, Greer JA, Pirl WF, Jackson VA, Ballen KK, Spitzer TR, Graubert TA, McAfee SL, Dey BR, Chen Y-BA, Temel JS (2015) Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation. Cancer 121(6):951–959CrossRefPubMed
5.
Simoneau TL, Mikulich-Gilbertson SK, Natvig C, Kilbourn K, Spradley J, Grzywa-Cobb R, Philips S, McSweeney P, Laudenslager ML (2013) Elevated peri-transplant distress in caregivers of allogeneic blood or marrow transplant patients. Psychooncology 22(9):2064–2070CrossRefPubMedPubMedCentral
6.
Beattie S, Lebel S (2011) The experience of caregivers of hematological cancer patients undergoing a hematopoietic stem cell transplant: a comprehensive literature review. Psycho-Oncology 20(11):1137–1150CrossRefPubMed
7.
Singh AK, McGuirk JP (2016) Allogeneic stem cell transplantation: a historical and scientific overview. Cancer Res 76(22):6445–6451CrossRefPubMed
8.
Norkin M, Hsu JW, Wingard JR (2012) Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation. Semin Hematol 49(1):104–109CrossRefPubMed
9.
Hamilton BK, Law AD, Rybicki L, Abounader D, Dabney J, Dean R, Duong HK, Gerds AT, Hanna R, Hill BT, Jagadeesh D, Kalaycio ME, Lawrence C, McLellan L, Pohlman B, Sobecks RM, Bolwell BJ, Majhail NS (2015) Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients. Bone Marrow Transplant 50(9):1235–1240CrossRefPubMed
10.
Pillay B, Lee SJ, Katona L, Burney S, Avery S (2014) Psychosocial factors associated with quality of life in allogeneic stem cell transplant patients prior to transplant. Psychooncology 23(6):642–649CrossRefPubMed
11.
McQuellon R, Russell G, Rambo T, Craven B, Radford J, Perry J, Cruz J, Hurd D (1998) Quality of life and psychological distress of bone marrow transplant recipients: the ‘time trajectory’ to recovery over the first year. Bone Marrow Transplant 21(5):477–486CrossRefPubMed
12.
Poloméni A, Lapusan S, Bompoint C, Rubio MT, Mohty M (2016) The impact of allogeneic-hematopoietic stem cell transplantation on patients’ and close relatives’ quality of life and relationships. Eur J Oncol Nurs 21:248–256CrossRefPubMed
13.
Foster LW, McLellan L, Rybicki L, Dabney J, Copelan E, Bolwell B (2013) Validating the positive impact of in-hospital lay care-partner support on patient survival in allogeneic BMT: a prospective study. Bone Marrow Transplant 48(5):671–677CrossRefPubMed
14.
Ehrlich KB, Miller GE, Scheide T, Baveja S, Weiland R, Galvin J, Mehta J, Penedo FJ (2016) Pre-transplant emotional support is associated with longer survival after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 51(12):1594–1598CrossRefPubMed
15.
Northouse LL, Mood DW, Schafenacker A, Kalemkerian G, Zalupski M, LoRusso P, Hayes DF, Hussain M, Ruckdeschel J, Fendrick AM, Trask PC, Ronis DL, Kershaw T (2013) Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers. Psychooncology 22(3):555–563CrossRefPubMed
16.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381CrossRefPubMed
17.
McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A, Hurd DD (1997) Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 19(4):357–368CrossRefPubMed
18.
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579CrossRefPubMed
19.
Given CW, Given B, Stommel M, Collins C, King S, Franklin S (1992) The caregiver reaction assessment (CRA) for caregivers to persons with chronic physical and mental impairments. Res Nurs Health 15(4):271–283CrossRefPubMed
20.
Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1(3):385–401CrossRef
21.
Andresen EM, Malmgren JA, Carter WB, Patrick DL (1994) Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med 10(2):77–84CrossRefPubMed
22.
Spielberger CD, Gorsuch RL (1983) Manual for the State-Trait Anxiety Inventory (Form Y): self-evaluation questionnaire. Consulting Psychologists Press, Palo Alto
23.
Raveis VH, Karus D, Pretter S (2000) Correlates of anxiety among adult daughter caregivers to a parent with cancer. J Psychosoc Oncol 17(3–4):1–26CrossRef
24.
Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24(4):385–396CrossRefPubMed
25.
Cohen LU, Kessler S, Gordon RC (1995) Measuring stress: a guide for health and social scientists. Oxford University Press New York, New York
26.
Lee E-H (2012) Review of the psychometric evidence of the perceived stress scale. Asian Nurs Res (Korean Soc Nurs Sci) 6(4):121–127CrossRef
27.
Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213CrossRefPubMed
28.
Buysse DJ, Reynolds CF, Monk TH, Hoch CC, Yeager AL, Kupfer DJ (1991) Quantification of subjective sleep quality in healthy elderly men and women using the Pittsburgh Sleep Quality Index (PSQI). Sleep 14(4):331–338PubMed
29.
Deeken JF, Taylor KL, Mangan P, Yabroff KR, Ingham JM (2003) Care for the caregivers: a review of self-report instruments developed to measure the burden, needs, and quality of life of informal caregivers. J Pain Symptom Manag 26(4):922–953CrossRef
30.
Grov EK, Fossa SD, Tonnessen A, Dahl AA (2006) The caregiver reaction assessment: psychometrics, and temporal stability in primary caregivers of Norwegian cancer patients in late palliative phase. Psychooncology 15(6):517–527CrossRefPubMed
31.
Shaw BE, Lee SJ, Horowitz MM, Wood WA, Rizzo JD, Flynn KE (2016) Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN. Bone Marrow Transplant 51(9):1173–1179CrossRefPubMed
32.
Kopp M, Schweigkofler H, Holzner B, Nachbaur D, Niederwieser D, Fleischhacker WW, Kemmler G, Sperner-Unterweger B (2000) EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison. Eur J Haematol 65(2):97–103CrossRefPubMed
33.
Muthén LK, Muthén BO (1998–2011) Mplus user’s guide, 6th edn. Muthén & Muthén, Los Angeles
34.
Cook W, Kenny D (2005) The actor-partner interdependence model: a model of bidirectional effects in developmental studies. Int J Behav Dev 29(2):101–109CrossRef
35.
Majhail NS, Nayyar S, Santibañez MEB, Murphy EA, Denzen EM (2012) Racial disparities in hematopoietic cell transplantation in the United States. Bone Marrow Transplant 47(11):1385–1390CrossRefPubMed
36.
Kershaw TS, Mood DW, Newth G, Ronis DL, Sanda MG, Vaishampayan U, Northouse LL (2008) Longitudinal analysis of a model to predict quality of life in prostate cancer patients and their spouses. Ann Behav Med 36(2):117–128CrossRefPubMed
37.
Gaston-Johansson F, Lachica EM, Fall-Dickson JM, John Kennedy M (2004) Psychological distress, fatigue, burden of care, and quality of life in primary caregivers of patients with breast cancer undergoing autologous bone marrow transplantation. Oncol Nurs Forum 31(6):1161–1169CrossRefPubMed
38.
Wells KJ, Booth-Jones M, Jacobsen PB (2009) Do coping and social support predict depression and anxiety in patients undergoing hematopoietic stem cell transplantation? J Psychosoc Oncol 27(3):297–315CrossRefPubMed
39.
Fife CA, Fausel BL (2010) Hematopoietic dyscrasias and stem cell/bone marrow transplantation. In: Holland JC, Breitbart WS, Jacobsen PB, Lederberg MS, Loscalzo MJ (eds) Psycho-oncology, & R. M. Oxford University Press, New York, pp 191–195CrossRef
40.
El-Jawahri A, Chen Y-B, Brazauskas R, He N, Lee SJ, Knight JM, Majhail N, Buchbinder D, Schears RM, Wirk BM, Wood WA, Ahmed I, Aljurf M, Szer J, Beattie SM, Battiwalla M, Dandoy C, Diaz M-A, D’Souza A, Freytes CO, Gajewski J, Gergis U, Hashmi SK, Jakubowski A, Kamble RT, Kindwall-Keller T, Lazarus HM, Malone AK, Marks DI, Meehan K, Savani BN, Olsson RF, Rizzieri D, Steinberg A, Speckhart D, Szwajcer D, Schoemans H, Seo S, Ustun C, Atsuta Y, Dalal J, Sales-Bonfim C, Khera N, Hahn T, Saber W (2017) Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation. Cancer 123(10):1828–1838CrossRefPubMed
41.
Laudenslager ML, Simoneau TL, Kilbourn K, Natvig C, Philips S, Spradley J, Benitez P, McSweeney P, Mikulich-Gilbertson SK (2015) A randomized control trial of a psychosocial intervention for distress in caregivers of allogeneic hematopoietic stem cell transplant patients: effects on distress. Bone Marrow Transplant 50:1110–1118CrossRefPubMedPubMedCentral
42.
Broderick JE, DeWitt EM, Rothrock N, Crane PK, Forrest CB (2013) Advances in patient-reported outcomes: the NIH PROMIS(®) measures. EGEMS (Washington, DC) 1(1):1015
43.
Jacobsen PB (2007) Screening for psychological distress in cancer patients: challenges and opportunities. J Clin Oncol 25(29):4526–4527CrossRefPubMed
44.
Wulff-Burchfield EM, Jagasia M, Savani BN (2013) Long-term follow-up of informal caregivers after Allo-SCT: a systematic review. Bone Marrow Transplant 48(4):469–473CrossRefPubMed
45.
Pillay B, Lee SJ, Katona L, Burney S, Avery S (2014) Psychosocial factors predicting survival after allogeneic stem cell transplant. Support Care Cancer 22(9):2547–2555CrossRefPubMed
Metadata
Title
Distress and quality of life in patient and caregiver dyads facing stem cell transplant: identifying overlap and unique contributions
Authors
Timothy S. Sannes
Teresa L. Simoneau
Susan K. Mikulich-Gilbertson
Crystal L. Natvig
Benjamin W. Brewer
Kristin Kilbourn
Mark L. Laudenslager
Publication date
01-06-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 6/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4496-3

Other articles of this Issue 6/2019

Supportive Care in Cancer 6/2019 Go to the issue

Original Article

Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated “same-day” (< 24 h), “per-guidelines” (24–72 h), and “late” (> 72 h): findings from the MONITOR-GCSF study

Original Article

Design, implementation, and evaluation of an intervention to improve referral to smoking cessation services in breast cancer patients

Original Article

Grandparents of children with cancer: a controlled comparison of perceived family functioning

Letter to the Editor

Factors influencing magnesium infusions in hematopoietic cell transplants

Original Article

Opioid switching and variability in response in pain cancer patients

Commentary

Cancer survivorship care plans, financial toxicity, and financial planning alleviating financial distress among cancer survivors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits